Adenosine, mast cells and asthma

Inflammation Research

Volumn 48, Issue 6, 1999, Pages 301-307

  Forsythe, P ^a   Ennis, M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Adenosine; Asthma; Mast cells

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ASTEMIZOLE; BRONCHOCONSTRICTING AGENT; CALCIMYCIN; CELL SURFACE RECEPTOR; COMPOUND 48-80; CONCANAVALIN A; CROMOGLYCATE DISODIUM; DIPYRIDAMOLE; ENPROFYLLINE; FLURBIPROFEN; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E ANTIBODY; IPRATROPIUM BROMIDE; METHACHOLINE; NEDOCROMIL SODIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; TERFENADINE; THEOPHYLLINE; UNINDEXED DRUG;

ASTHMA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAST CELL; MODEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW;

ADENOSINE; ANIMALS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE; HUMANS; MAST CELLS; RECEPTORS, PURINERGIC P1;

EID: 0032813963     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050464     Document Type: Review

References (73)

1. Marquardt DL, Grober HE, Wasserman SI. Adenosine release from stimulated mast cells. Proc Natl Acad Sci USA 1984; 81: 6192-6.
2. Fredholm BB. Release of adenosine from rat lung by antigen and compound 48/80. Acta Physiol Scand 1981; 111: 507-8.
3. Mentzer RM, Rubio R, Berne RM. Release of adenosine from hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol 1975; 229: 1625-31.
4. Mann JS, Renwick AG, Holgate ST. Release of adenosine and its metabolites from activated human leucocytes. Clin Sci 1986; 70: 461-8.
5. Driver AG, Kukoly CA, Ali S Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993; 148: 91-7.
6. Coleman RA. Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol 1976; 57: 51-7.
7. Fredholm BB, Brodin K, Strandberg K. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors. Acta Pharmacol Toxicol 1979; 45: 336-44.
8. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Pharmacol 1983; 15: 161-5.
9. Mann JS, Holgate ST, Renwich AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61: 1667-6.
10. Fredholm BB. Are methylxanthines' effects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1980; 1: 129-32.
11. Cushley MJ, Tattersfield AE, Holgate ST. Adcnosine induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am Rev Respir Dis 1984; 129: 380-4.
12. Mann JS, Holgate ST. Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline. Br J Clin Pharmacol 1985; 19: 685-92.
13. Clarke H, Cushley MJ, Persson CG, Holgate ST. The protective effects of intravenous theophylline and enprofylline against histamine and adenosine 5′-monophosphate provoked bronconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol 1989; 2:147-54.
14. Cushley MJ, Tallant N, Holgate ST. The effect of single dose intravenous dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. Eur J Respir Dis 1986; 86:185-92.
15. Crimi N, Palermo F, Oliveri R, Maccarrone C, Palermo B, Vancheri C, et al. Enhancing effects of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients. Allergy 1988; 43:179-83.
16. Mann JS, Holgate ST, Renwich AG, Cushley MJ. Airway effects of purine nucleosides and nucleotidesand release withbronchial provocation in asthma. J Appl Physiol 1986; 61:1667-76
17. Mann JS, Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma: role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis 1985; 132: 1-6
18. Polsa R, Phillips CD, Rajakulasingham K, Holgate ST. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J Allergy Clin Immunol 1991; 87: 939-47
19. Richards R, Philips CD, Holgate ST. Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asmatic subjects. Clin Exp Allergy 1989; 19: 285-97.
20. Philips GD, Scott VL, Richards R, Holgate ST. Comparative protective effects of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate in non-atopic asthma. Eur Respir J 1989; 2: 210-7.
21. Polosa R, Ng WH, Crimi N, Vancheri C, Holgate ST, Church MK, et al. Release of mast celi derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995: 151:624-9.
22. Okazaki T, Namae A. Enhancement of anaphylaxis of isolated smooth muscle by adenosine and adenosine phosphates and inhibition of anaphylactic mechanisms by adenosine 3′-5′-cyclic monophosphates. Experientia 1972; 28: 426-7.
23. Marquardt DL, Parker CW, Sullivin TJ. Potentiation of mast cell mediator release by adenosine. J Immunol 1978; 120: 871-8.
24. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein M, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988; 138: 1143-51.
25. 2-receptor mediated mechanism. Pharmacol 1983; 84: 719-26.
26. Rafferty P, Beasley R, Southgate P, Holgate S. The role of histamine in allergen and adenosine-induced bronchoconstriction. Int Archs Allergy Appl Immun 1987; 82: 292-4.
27. Marquardt DL, Walker LL, Wasserman SI. Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by amonophylline. J Immunol 1984; 133: 932-7.
28. Philips GD, Holgate ST. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in non-atopic asthma. Am Rev Respir Dis 1989; 139:463-9.
29. Bradding P, Roberts JA, Britten KM, Montrfort S, Djukanovic R, Mueller R, et al. Interleukins-4,-5 and -6 and TNFα in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
30. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway responsiveness. Chest 1994; 105: 687-97.
31. Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, et al. Human mast cells produce IL-8. J Immunol 1993; 151: 3261-6.
32. 2 receptors evoke interleukin-8 secretion in human mast cells. J Clin Invest 1995; 96: 1979-86.
33. 1 adenosine receptor. FASEB J 1991; 5: 2668-76.
34. Stiles GL. Adenosine receptors. J Biol Chem 1992; 267: 6451-4.
35. Stiles GL, Olah ME. Adenosine receptors. Annu Rev Physiol 1992; 54: 211-27.
36. 3 receptors: pharmacological properties species differences and receptor functions. Trends Pharmacol Sci 1994; 15: 298-306.
37. 3 adenosine receptor. Proc Natl Acad Sci USA 1993; 90: 16887-90.
38. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993; 23: 168874-90.
39. 2 purinoreceptor mechanism. Biochem Pharmacol 1984; 23: 3847-52.
40. Church MK, Hughes PJ, Vardey CJ. Studies on the receptor mediating cyclic AMP-indepcndent mediator release from rat mast cells. Br J Pharmacol 1986; 87: 233-42.
41. Leoutsakos A, Trunech A, Pearce FL. Role of cyclic AMP in the induction of histamine secretion from mast cells. Agents Actions 1985; 16:126-8.
42. Leoutsakos A, Pearce FL. The effect of adenosine and its analogues on cyclic AMP changes and histamine secretion from rat peritoneal mast cells stimulated by various ligands. Biochem Pharmacol 1986; 35: 1373-79.
43. Marquardt DL, Walker LL. Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness. Agents Actions 1994; 43: 7-12.
44. Marquardt DL, Walker LL, Pretreatment with phorbol esters abrogates mast cell adenosine responsiveness. J Immunol 1989; 142: 1268-73.
45. 3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. J Immunol 1995; 154: 5436-43.
46. Meade CJ, Mierau J, Leon I, Ensinger HA. In vivo role of the adenosine A (3) receptor - N-6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally - mediated mechanism involving cells resembling mast cells. J Pharmacol Exp Ther 1996 279: 1148-56.
47. 3 adenosine receptor with wide spread tissue distribution. Mol Pharmacol 1993; 44: 524-32.
48. 3 adenosine receptor. Proc Natl Acad Sci USA 1993; 90: 10365-9.
49. Burl DS, Stanworth DR. The effect of ribose and purine modified adenosine analogues on the secretion of histamine from rat mast cells induced by ionophore A23187. Biochem Pharmacol 1983; 32: 2729-32.
50. Leoutsakos A, Pearce FL. The effect of adenosine and its analogues on cyclic AMP changes and histamine secretion from rat peritoneal mast cells stimulated by various ligands. Biochem Pharmacol 1986; 35: 1373-9.
51. 2 receptor in Xenopus oocytes. Mol Pharmacol 1993; 43: 277-81.
52. 2 receptor. Mol Pharmacol 1997; 52: 846-60.
53. Marquardt DL, Walker LL, Heinemann S. Modulation of mast cell responses to adenosine by agents that alter protein kinase C activity. Biochem Pharmacol 1990; 39: 1929-34.
54. Pauwels R, Van der Straeten M. An animal model of adenosine-induced bronchoconstriction. Am Rev Respir Dis 1987; 136:374-8.
55. Pauwels RA, Joos GF. Characterization of the adenosine receptors in the airways. Arch Int Pharmacodyn Ther 1995; 329: 151-60.
56. Ali S, Mustafa SJ, Metzger WJ. Adenosine receptor mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. Am J Physiol 1994; 266: L271-7.
57. Nyce JW, Metzger WJ. DNA antisense therapy for asthma in an animal model. Nature 1997; 385: 721-5.
58. Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984; 129: 1000-5.
59. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperresponsiveness. Am Rev Resp Dis 1988; 137: 62-9
60. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, et al. Flevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987; 79:1197-203.
61. Leung KBP, Flint KC, Brostoff J, Hudspith BN, Johnson NMCI, Lau HYA, et al. Effects of sodium cromoglycate on histamine secretion from human lung mast cells. Thorax 1988; 43: 756-61.
62. Heaney LG, Cross LMJ, Stanford CF, Ennis M. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy 1995; 25: 179-86.
63. Forsythe P, Mc Garvey LPA, Heaney LG, MacMahon J, Ennis M. Adenosine induces histamine release from human bronchoalveolar lavage mast cells. Clin Sci, 1999; 96: 349-55.
64. Fozard JR, Pfannkuche HJ, Schuurman HJ. Mast cell degranulation following adenosine A(3) receptor activation in rats. Eur J Pharmacol 1996; 298: 293-7.
65. Reeves JJ, Jones CA, Sheehan MJ, Vardey CJ, Whelan CJ. Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Res 1997; 46: 180-4.
66. Heaney LG, Cross LJM, Ennis M. Histamine release from human bronchoalveolar lavage cells from asthmatic subjects after allergen challenge and relationship to the late asthmatic response. Clin Exp Allergy 1998; 28: 196-204.
67. Laitinen LA, Ileino M, Laitenen A, Kava T, Hauhtela T, Damage to the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606.
68. Montefort S, Gratziou C, Goulding D, Haskard DO, Howarth PH, Holgate ST. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93: 1411-21.
69. Marquardt DL, Walker LL, Heinemann S. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 1994; 152: 4508-15.
70. Kim HO, Ji XD, Siddiqi SM, Olah ME, Stiles GL, Jacobson KA. 2-Substitution of N-6-benzyladenosine-5′-Uronamides enhances selectivity for A-3 adenosine receptors. J Med Chem 1994; 37: 3614-21.
71. Kim YC, Ji XD, Jacobson KA. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A(3) receptor subtype. J Med Chem 1996; 39: 4142-8.
72. Li AH, Moro S, Melman N, Ji XD, Jacobson KA. Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkyl-pyridine derivatives as selective A(3) adenosine receptor antagonists. J Med Chem 1998; 41: 3186-201.
73. Franchelli P, Cappellacci L, Marchetti S, Trincavelli L, Martini C, Mazzoni MR, et al. 2′-C-methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies. J Med Chem 199841: 1708-15.